Sessions are scheduled in Singapore Time (SGT)

Displaying One Session

Time
12:45 - 14:15

Welcome and introduction

Survival outcomes with first-line CDK4/6i in patients with HR+/HER2– ABC

Second-line treatment options for patients with HR+/HER2− ABC

Round table discussion

Key takeaways and live Q&A session